Hi Key Sole
Earlier approval for the tests would have been a great boon, and other players in the testing space have limited sales of GSS kits. Not saying there has been no positive upside, just that it could have been so much better had a few things gone more favourably the way of the company. I see strength in the diversification of their testing.
Ann: First quarter sales update, page-5
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.0¢ |
Change
0.050(8.06%) |
Mkt cap ! $152.0M | |||
| Open | High | Low | Value | Volume |
| 62.8¢ | 67.0¢ | 62.8¢ | $194.6K | 299.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3757 | 67.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 5952 | 1 |
View Market Depth
| Last trade - 15.12pm 31/10/2024 (20 minute delay) ? |
| GSS (ASX) Chart |